Claris Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$566K Sell
2,314
-24
-1% -$5.59K 0.17% 41
2025
Q4
$484K Sell
2,338
-1,099
-32% -$217K 0.15% 45
2025
Q3
$525K Hold
3,437
0.18% 41
2025
Q2
$525K Buy
3,437
+1,254
+57% +$193K 0.18% 41
2025
Q1
$362K Buy
2,183
+118
+6% +$18.5K 0.13% 53
2024
Q4
$299K Buy
2,065
+570
+38% +$88.3K 0.11% 56
2024
Q3
$242K Buy
1,495
+72
+5% +$11.5K 0.11% 55
2024
Q2
$208K Sell
1,423
-80
-5% -$11.9K 0.11% 55
2024
Q1
$238K Hold
1,503
0.12% 49
2023
Q4
$236K Hold
1,503
0.13% 46
2023
Q3
$234K Hold
1,503
0.15% 41
2023
Q2
$249K Hold
1,503
0.17% 40
2023
Q1
$233K Sell
1,503
-162
-10% -$26.2K 0.17% 39
2022
Q4
$294K Sell
1,665
-96
-5% -$16.6K 0.28% 41
2022
Q3
$288K Sell
1,761
-197
-10% -$33.3K 0.33% 30
2022
Q2
$348K Sell
1,958
-204
-9% -$36.3K 0.38% 24
2022
Q1
$383K Buy
2,162
+66
+3% +$11.2K 0.41% 25
2021
Q4
$359K Buy
+2,096
New +$343K 0.38% 28

Other funds holding JNJ

Claris Advisors's JNJ Position: Q1 2026 in Review

Claris Advisors reduced its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, selling an estimated $5.59K and leaving 2,314 shares worth $566K. The position accounts for 0.17% of the portfolio, ranked #41.

Claris Advisors first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Claris Advisors held 2,314 shares of Johnson & Johnson worth $566K as of Q1 2026.
  • Claris Advisors sold 24 Johnson & Johnson shares in Q1 2026, an estimated $5.59K.
  • Johnson & Johnson made up 0.17% of Claris Advisors's portfolio in Q1 2026, its #41 holding.
  • Claris Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Claris Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.